GSK plc. Basic Information, Manufacturing Base, Sales Area, and Competitors
Sr. No. |
Item |
Description |
1 |
Company Name |
GSK plc. |
2 |
Website |
www.gsk.com |
3 |
Established Date |
2000 |
4 |
Headquartered |
United Kingdom |
5 |
Market Position/ History |
GSK plc. was founded in and is headquartered in Brentford, United Kingdom Glaxo Wellcome plc and SmithKline Beecham plc merged in 2001 to become GlaxoSmithKline plc (GSK), but GSK origins can be traced back to 1715. In 2009, a unique partnership with P?zer led to the launch of ViiV Healthcare, a company focused on delivering advanced treatment and care for HIV communities. In 2014, it submitted a file to the European Medicines Agency for the world’s first malaria-candidate vaccine. Since 2018, the WHO has piloted the vaccine in Ghana, Kenya, and Malawi. The company has been producing tuberculosis vaccines for children for more than 60 years. In 2020, a new tuberculosis vaccine candidate was licensed to the Gates Medical Research Institution after positive trials in adolescents and adults. The acquisition of Tesaro in 2019 has further strengthened the company's oncology portfolio and pipeline, with new treatments for ovarian, multiple myeloma, and endometrial cancer. In 2022, GSK reborned as a company solely focused on the development of new medicines and vaccines. |
6 |
Sales Area |
Worldwide |
7 |
Manufacturing Location |
The company has manufacturing sites across all the regions worldwide. It has 37 vaccines and medicines manufacturing sites |
8 |
Ticker |
LON: GSK |
9 |
No. of Employees |
70,212 employees by December 2023 |
10 |
Competitors |
|
11 |
CEO |
Emma Walmsley |
12 |
Ownership Type |
Public |
13 |
Contact Information |
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom Tel: +44 20 8047 5000 |
Business Segment/ Overview:
GSK plc. is a biopharma company. It is developing vaccines and specialty medicines to prevent and treat disease. The company offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, urogenital, anti-bacterial, dermatology, and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastrointestinal diseases. Furthermore, its vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles, and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians, and other groups worldwide.
Anti-Obesity Drugs Product Types Specification
Product |
Product Description |
alli (orlistat 60 mg) |
Alli for adults with a BMI of 28 kg/m2 or more alli, is indicated for weight loss in adults, with a BMI 28 kg/m2 or more, when used along with a reduced calorie, lower-fat diet. The recommended dose of alli is one 60 mg capsule three times a day with meals containing the recommended amount of fat.
|
Author's Detail:
Sneha Mali /
LinkedIn
Sneha Mali is a research analyst working in various domains including the Consumer Goods, market research and transport & logistics and her primary responsibility is to conduct thorough research on various subjects and provide valuable insights to support client requirements. Her knowledge of research methodologies, and data mining which enables me to analyze large data sets, draw meaningful conclusions, and communicate them effectively.Sneha stay up-to-date with the latest research trends, methodologies, and technologies to ensure that her research is accurate, relevant, and impactful.
In her current role, Sneha is committed to continuous learning and staying abreast of emerging trends in research methodologies. Regular participation in workshops, webinars, and industry conferences ensures that her skills remain sharp and relevant. She have demonstrated ability to transform complex data sets into clear and concise narratives that inform key business strategies. Collaborating with cross-functional teams.Sneha remains an invaluable asset in the dynamic landscape of market research.